Vimarsana
Biggest News Aggregation in the World

Life Sciences Partner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Sciences Partner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Sciences Partner Today - Breaking & Trending Today

Coulter Partners Top hires for VC & PE portfolio companies Q1-2024 - Vimarsana News

Coulter Partners Top hires for VC & PE portfolio companies Q1-2024

Search HighlightsRecent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.This quarter’s successful placements include:FunctionFocus areaLocationCEOTherapeutic devicesAustriaChief Business Officer...

IQVIA Holdings Inc. (NYSE:IQV) Q2 2023 Earnings Call Transcript - Vimarsana News

IQVIA Holdings Inc. (NYSE:IQV) Q2 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thanks for standing by. At this time, I would like to welcome everyone to the IQVIA Second Quarter 2023 Earnings Conference Call.

Fujitsu Recognized As Winner Of 2023 Microsoft Japan Healthcare & Life Sciences Partner Of The Year Award - Vimarsana News

Fujitsu Recognized As Winner Of 2023 Microsoft Japan Healthcare & Life Sciences Partner Of The Year Award

Further recognition as winner of the Microsoft Japan Global System Integrator (GSI) award and Government award categories, and selection as finalist in GSI award, SAP on Azure award, Defense & Intelligence award categories of the Microsoft ...

Volpara recognized as the winner of 2023 Microsoft Healthcare & Life Sciences Partner of the Year - Vimarsana News

Volpara recognized as the winner of 2023 Microsoft Healthcare & Life Sciences Partner of the Year

/PRNewswire/ -- Volpara Health (ASX: VHT), a global leader in software for the early detection of breast cancer, today announced it has won the Healthcare &...

Invirsa Completes $7.7M Series B Financing - Vimarsana News

Invirsa Completes $7.7M Series B Financing

COLUMBUS, Ohio--(BUSINESS WIRE)--Invirsa Inc., a privately held, clinical-stage pharmaceutical company focused on developing an innovative topically administered eyedrop formulation INV-102 for ocular conditions associated with DNA damage, announced the closing of a $7.7 million Series B financing completed in April...